Target intelligence / Profile preview

General iron-dependent proteins and transporters

Molecular classification
Transporter, Carrier protein, Enzyme, Receptor
01

Overview

The term "general iron-dependent proteins and transporters" refers to a diverse set of molecules responsible for the binding, storage, transport, and catalytic utilization of iron in biological systems. Major iron transporters include Divalent metal transporter 1 (DMT1), ferroportin, ZIP family transporters, and transferrin receptor, while iron-dependent proteins encompass a range of enzymes (such as cytochromes, oxygenases, and iron-sulfur proteins) that require iron for their catalytic activity. These proteins play crucial roles in iron homeostasis, metabolic oxidation–reduction reactions, oxygen transport, immune defense, and various biosynthetic pathways. Dysfunction in iron-dependent proteins and transporters is implicated in a wide range of diseases including infection, anemia, cancer, and neurodegenerative disorders. Because "general iron-dependent proteins and transporters" is not a single molecular entity, this designation should be replaced with specific, functionally defined targets for most biomedical or pharmacological purposes.

Other names
Iron-binding proteinsIron transportersIron-dependent enzymes
02

Mechanism of action

None collectively. Major examples per individual protein include: Chelation (binding iron or interrupting iron transport); Inhibition of transporter function (e.g., blocking DMT1 to limit cellular iron uptake); Immunotargeting receptors for drug delivery.

03

Biological functions

Iron uptake and absorptionIron storage and traffickingElectron transport and redox reactionsOxygen transportMetabolic catalysis
04

Disease associations

InfectionCancerNeurodegenerative diseaseAnemiaOther metabolic diseases involving iron overload (e.g., hemochromatosis)
05

Safety considerations

Disruption of essential cellular iron homeostasis leading to anemia or iron overloadOff-target effects due to the ubiquity of iron transportersInfection risk, as manipulating iron availability impacts pathogen survival, too
06

Interacting drugs

Deferoxamine

3 more in the full profile.

07

Biomarkers

Transferrin saturationFerritin levelsDMT1 expression

Beyond the preview

Go deeper on General iron-dependent proteins and transporters.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General iron-dependent proteins and transporters.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call